Updates in Breast Cancer from San Antonio


 

SABCS 2019 Highlights: Tucatinib + Trastuzumab + Capecitabine May Become the New SoC in HER2+ Metastatic Breast Cancer

140 views
February 10, 2020
0 Comments
Login to view comments. Click here to Login